Smith & Nephew BACTIGRAS Wound Dressing Singapore - engelsk - HSA (Health Sciences Authority)

smith & nephew bactigras wound dressing

smith & nephew pte. limited - general hospital - bactigras is for use as a topical treatment only. it is indicated for a wide range of wounds where there is a risk of infection, or on already infected wounds in conjunction with systemic antibacterial agents. the range of wounds on which bactigras may be used include: • minor burns and scalds • lacerations, abrasions and other skin loss wounds • donor and recipient graft sites

Xigris New Zealand - engelsk - Medsafe (Medicines Safety Authority)

xigris

eli lilly and company (nz) limited - drotrecogin alfa (activated) 20mg ([recombinant human acitvated protein c (rhapc)]) - powder for infusion - 20 mg - active: drotrecogin alfa (activated) 20mg ([recombinant human acitvated protein c (rhapc)]) excipient: hydrochloric acid citrate buffer (containing citrate, citric acid, hcl, naoh) hydrochloric acid sodium chloride sodium hydroxide sucrose water for injection

Xigris New Zealand - engelsk - Medsafe (Medicines Safety Authority)

xigris

eli lilly and company (nz) limited - drotrecogin alfa (activated) 5mg ([recombinant human acitvated protein c (rhapc)]) - powder for infusion - 5 mg - active: drotrecogin alfa (activated) 5mg ([recombinant human acitvated protein c (rhapc)]) excipient: hydrochloric acid citrate buffer (containing citrate, citric acid, hcl, naoh) hydrochloric acid sodium chloride sodium hydroxide sucrose water for injection

XIGRIS 20 mg Powder Sydafrika - engelsk - South African Health Products Regulatory Authority (SAHPRA)

xigris 20 mg powder

eli lilly (sa) (pty) ltd - powder - each vial contains drotrecogin alpha 20,0 mg